Kilele Health provides the SunVida System, a platform that delivers real-time, longitudinal molecular information previously inaccessible outside clinical settings. This system transforms complex biology into actionable insights, enabling more personalized treatment decisions and earlier intervention for chronic disease management. By solving aptamer longevity challenges, the platform supports continuous, data-driven care guided by in-body biochemistry.
Funding
Funding not disclosed
Founders
Product
Problem
Current remote patient monitoring (RPM) solutions primarily focus on non-biochemical data, leaving a critical gap in the real-time assessment of key physiological markers. This limitation hinders the proactive management of chronic conditions, potentially leading to delayed interventions and increased healthcare costs.
Solution
Kilele Health offers the SunVida™ wearable biochemical monitoring platform, designed to integrate real-time biochemical data into remote patient management programs. The platform utilizes proprietary aptamer sensor technology, addressing the historical challenge of aptamer longevity to provide consistent, factory-calibrated performance for extended periods. This enables continuous tracking of biomarkers such as phenylalanine, creatinine, potassium, and lactate, facilitating early detection of health deteriorations and supporting personalized treatment adjustments. By providing clinicians with actionable biochemical insights, SunVida™ aims to improve patient outcomes and reduce hospitalizations for individuals with chronic diseases like phenylketonuria, heart failure, and multimorbidity.
Target Audience
The primary target audience includes healthcare providers, hospital systems, and researchers focused on chronic disease management, particularly those involved in remote patient monitoring and personalized medicine initiatives.
Features
- SunVida™ wearable platform leveraging next-generation aptamer sensor technology for in-vivo biochemical monitoring.
- Patented solution to aptamer longevity, ensuring consistent, factory-calibrated sensor performance for weeks.
- Real-time tracking of multiple biomarkers including phenylalanine, creatinine, potassium, and lactate.
- Aptamer-based assays capable of quantifying a broad range of human proteome markers.
- Device format designed for user comfort and integration into daily routines, similar to continuous glucose monitors.
- Cloud-based data transmission and analytics for remote patient data interpretation.
- Application development for specific chronic conditions including Phenylketonuria (PKU), Heart Failure (HF), and multimorbidity.